Assessment of metabolic biomarkers associated with hepatic steatosis in Crohn’s disease

Table 3 Biochemical and metabolic parameters according to study groups (mean value)

Variable	CD remission	Active CD	Healthy controls	Statistical significance
Total cholesterol (mg/dL)	186	174	179	0.6
Triglycerides (mg/dL)	134	101	87	0.04
LDL cholesterol (mg/dL)	133	113	98	0.09
HDL cholesterol (mg/dL)	54	52	61	0.1
ALT (U/L)	30	21	24	0.06
AST (U/L)	22	20	17	0.08
GGT (U/L)	31	21	23	0.1
ALP (U/L)	80	87	89	0.01
Apolipoprotein B	101	85	78	0.1
HOMA index	2.54	1.45	2.98	0.09
HbA1c (mmol/mol)	17.7	35.5	5.8	0.02

CD: Crohn’s disease; LDL: Low-density lipoprotein; HDL: High-density lipoprotein; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; ALP: Alkaline phosphatase; HOMA: Homeostasis model assessment; HbA1c: Glycated hemoglobin.